drugset / Trial / NCT00901199
Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload
NaSingle-groupOpen-labelTreatment
Summary
This is a pilot study looking at the safety and efficacy of giving combination chelation with deferasirox and deferoxamine. The hypothesis is that combination chelation is safe in decreasing overall iron in patients with thalassemia.
Timeline
- Start
- 2007-09
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deferasirox | Unknown | 20 mg/kg | — |
| Subject | Deferasirox | Unknown | 30 mg/kg | — |
| Subject | Deferoxamine | Other / unclassified | 50 mg/kg | — |